(isatuximab) Phase 3 trial met primary endpoint of progression free survival in patie | IMGN Message Board Posts


IMGN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  57275 of 57658  at  12/7/2023 12:22:38 PM  by

GaryM


 In response to msg 57274 by  very
view thread

Re: (isatuximab) Phase 3 trial met primary endpoint of progression free survival in patie

More ammunition on why the buyout was priced too low. 
 
Gary  


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 0  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
57276 Re: (isatuximab) Phase 3 trial met primary endpoint of progression free survival in patie wal187lco 0 12/7/2023 2:21:13 PM




Financial Market Data provided by
.
Loading...